AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$1.1B |
| 2 |
Entegris
ENTG
|
+$659M |
| 3 |
Autodesk
ADSK
|
+$618M |
| 4 |
Zebra Technologies
ZBRA
|
+$614M |
| 5 |
Nike
NKE
|
+$536M |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$1.39B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.31B |
| 3 |
Take-Two Interactive
TTWO
|
+$567M |
| 4 |
Verisk Analytics
VRSK
|
+$407M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$394M |
Sector Composition
| 1 | Technology | 26.03% |
| 2 | Healthcare | 16.1% |
| 3 | Consumer Discretionary | 12.27% |
| 4 | Financials | 11.96% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
QCR Holdings
QCRH
$1.32B
| $772K | ﹤0.01% |
13,639
+7,200
| +112% | +$408K |
|
2502
First Mid Bancshares
FMBH
$954M
| $771K | ﹤0.01% |
20,037
-775
| -4% | -$29.8K |
|
2503
Organogenesis Holdings
ORGO
$617M
| $766K | ﹤0.01% |
100,579
+291
| +0.3% | +$2.22K |
|
2504
Fastly
FSLY
$1.08B
| $757K | ﹤0.01% |
43,572
-2,189
| -5% | -$38K |
|
2505
Lyell Immunopharma
LYEL
$251M
| $755K | ﹤0.01% |
+7,473
| New | +$755K |
|
2506
nCino
NCNO
$3.47B
| $754K | ﹤0.01% |
18,401
-439,480
| -96% | -$18M |
|
2507
Pulmonx
LUNG
$65.6M
| $752K | ﹤0.01% |
30,300
| – | – |
|
|
AFAC
2508
DELISTED
Arena Fortify Acquisition Corp. Class A Common Stock
AFAC
| $751K | ﹤0.01% |
+75,000
| New | +$751K |
|
2509
MBIA
MBI
$374M
| $750K | ﹤0.01% |
48,759
+2,059
| +4% | +$31.7K |
|
2510
iShares Russell Mid-Cap Growth ETF
IWP
$20.5B
| $746K | ﹤0.01% |
7,422
+2,614
| +54% | +$263K |
|
|
SRNE
2511
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $746K | ﹤0.01% |
320,100
+900
| +0.3% | +$2.1K |
|
|
TMAC
2512
DELISTED
The Music Acquisition Corporation
TMAC
| $746K | ﹤0.01% |
76,500
| – | – |
|
2513
Douglas Dynamics
PLOW
$751M
| $744K | ﹤0.01% |
21,500
-700
| -3% | -$24.2K |
|
2514
Theravance Biopharma
TBPH
$687M
| $743K | ﹤0.01% |
77,735
+200
| +0.3% | +$1.91K |
|
2515
OptimizeRx
OPRX
$326M
| $738K | ﹤0.01% |
19,559
+25
| +0.1% | +$943 |
|
2516
Central Pacific Financial
CPF
$834M
| $731K | ﹤0.01% |
26,190
+11,603
| +80% | +$324K |
|
2517
Technology Select Sector SPDR Fund
XLK
$86.3B
| $729K | ﹤0.01% |
+4,586
| New | +$729K |
|
|
AMRS
2518
DELISTED
Amyris Inc.
AMRS
| $728K | ﹤0.01% |
167,000
-42,500
| -20% | -$185K |
|
2519
Horizon Bancorp
HBNC
$839M
| $727K | ﹤0.01% |
38,933
+22,055
| +131% | +$412K |
|
2520
Sapiens International
SPNS
$2.4B
| $725K | ﹤0.01% |
28,549
| – | – |
|
2521
FS KKR Capital
FSK
$4.98B
| $724K | ﹤0.01% |
31,715
| – | – |
|
2522
OrthoPediatrics
KIDS
$484M
| $723K | ﹤0.01% |
13,385
+985
| +8% | +$53.2K |
|
2523
Construction Partners
ROAD
$6.95B
| $723K | ﹤0.01% |
27,600
+100
| +0.4% | +$2.62K |
|
2524
Aclaris Therapeutics
ACRS
$221M
| $721K | ﹤0.01% |
41,800
+9,200
| +28% | +$159K |
|
2525
Hydrofarm Holdings
HYFM
$15.1M
| $713K | ﹤0.01% |
4,703
-178,908
| -97% | -$27.1M |
|